SMALES KELLY sold 4.4% of their position (3.88K shares) of TRANSPHORM, INC. on the open market
Open‑market sale worth $11.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/21/2023ACC: 0001209191-23-056270
-3.88K
Net shares
Net seller
$11.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.88K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.23K
Price / share
$2.82
Trade value
$9.09K
% of position
3.7%
11/17/2023
87.51K→84.28K
Common Stock
Direct
Shares
−656.00
Price / share
$2.89
Trade value
$1.89K
% of position
0.8%
11/20/2023
84.28K→83.63K
Total
Net shares
−3.88K
Net value
-$10.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2023 | S · Sale | −3.23K | $2.82 | $9.09K | 3.7% | 87.51K | 84.28K |
| Common Stock Direct | 11/20/2023 | S · Sale | −656.00 | $2.89 | $1.89K | 0.8% | 84.28K | 83.63K |
| Total | −3.88K | -$10.99K | ||||||
Derivative Transactions0
No derivative transactions reported